Do not use this content to diagnose, treat, or dose yourself
UK Guide Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for type 2 diabetes mellitus, not weight management
GSH, as an antioxidant, is oxidized to GSSG after clearing free radicals and toxins
Additionally, people with multiple weight-related health conditionssuch as type 2 diabetes and hypertensionoften benefit from controlled, gradual activation of GLP-1 signaling to avoid acute changes in blood glucose or blood pressure
Anyone with symptoms or a diagnosis of a serious disease people should seek conventional treatment from a qualified medical professional
On this podcast, we will also answer your questions about strength, health, and wellbeing